Similarly, others have found that high-fat dietinduced obesity results in lymphatic impairment with decreased lymphatic endothelial cell expression of lymphatic-related genes and that mice with diet-induced obesity develop exaggerated deficits after injury. [6] [7] [8] Such studies suggest that there may be a subset of patients in whom abnormal lymphatic development and/or dysregulation contribute to subclinical lymphatic dysfunction with a consequent elevated lymphedema risk. However, the means by which lymphatic abnormalities affect the development of lymphedema remain unclear. Elucidation of these pathways is critical, as it could allow for the implementation of preventative/therapeutic options in patients with such predisposition.
Because Prospero homeobox protein 1 (Prox1) is essential for lymphatic endothelial cell maintenance and migration, 9, 10 mice that are heterozygous for the gene have subclinical lymphatic disease. 11 Homozygous deletion results in embryonic lethality associated with severe edema secondary to the absence of lymphatic vessels, but haploinsufficient (Prox1 +/-) mice appear normal without overt evidence of edema. 9, 12 Knowing this, we used popliteal lymph node dissection to induce lymphatic injury in Prox1 +/-mice to evaluate the effect of baseline lymphatic abnormalities on lymphedema pathogenesis.
MATERIALS AND METHODS

Animals
All experiments were approved by the Memorial Sloan Kettering Cancer Center Institutional Animal Care and Use Committee. Weight-matched 6-week-old male C57BL/6 mice (henceforth referred to as wild-type or wild-type mice) were purchased from Taconic Biosciences (Hudson, N.Y.) and Prox1 +/-mice were donated by Dr. Guillermo Oliver (Northwestern University, Chicago, Ill.). 9 [See Figure, Supplemental Digital Content 1, which shows the the wild-type (WT) and Prox1 +/-mice were weight-matched. Quantification of weight (in grams) of wild-type and Prox1 +/-mice at baseline (unpaired t test, mean ± SD; n = 4 to 5 per group; p = 0.41), http://links.lww.com/PRS/D177.] All mice were maintained in a light-and temperature-controlled environment. A minimum of four animals per group were used for each experiment. When indicated, anesthesia was induced with isoflurane; tail pinch reflex and respiratory rate were monitored every 15 minutes to ensure adequate anesthesia. Euthanasia was conducted by carbon dioxide asphyxiation, as recommended by the American Veterinary Medical Association.
Popliteal Lymph Node Dissection
We used a well-described model of popliteal lymph node dissection to study the effects of lymphatic injury on inflammation, lymphatic function, and lymphangiogenesis. [13] [14] [15] After 30 µl of 3% Evans blue (Sigma-Aldrich, St. Louis, Mo.) in phosphate-buffered saline was injected into the dorsal hind paw to visualize the lymphatic system, the popliteal lymph node and its surrounding fat pad were excised, thereby removing both afferent and efferent vessels. The incision was closed with 3-0 continuous nonabsorbable suture.
Analysis of Lymphatic Vessel Morphology and Leakiness
The ears of wild-type and Prox1 +/-mice were injected with Evans blue or fluorescent tomato lectin to visualize the lymphatic vasculature. 16, 17 In the apices of the right ears, we injected 2 µl of 1% Evans blue, which was allowed to disperse for 1 minute before imaging. Similarly, we injected 3 µl of 1 mg/ml tomato lectin (Sigma-Aldrich) in the apices of the left ears, followed by harvest 10 minutes later for whole-mount staining as described below.
tail. 18 Images were obtained 15 minutes later at fixed 10-mm intervals using a SteREO Lumar V12 microscope (Zeiss, Munich, Germany) at fixed exposure, gain, and magnification.
Hindlimb lymphatic pumping and transport capacity were evaluated before and after popliteal lymph node dissection with near-infrared lymphangiography according to previously reported techniques. 20 A total of 15 µl of 0.15 mg/ml indocyanine green (Sigma-Aldrich) was injected intradermally into the dorsal hind paw after hindlimb hair was removed with Nair depilatory cream (Church & Dwight Co., Ewing, N.J.). After 30 minutes of free ambulation, the mice were anesthetized and placed under a SteREO Lumar V12 microscope (Zeiss) with an EVOS EMCCD camera (Life Technologies, Carlsbad, Calif.) and light-emitting diode light source (CoolLED, Andover, United Kingdom) for 30 minutes. Collecting lymphatic vessel contractions per minute (packet frequency) was determined by changes in indocyanine green intensity in a standard region of interest over the dominant vessel after subtracting background fluorescence using Fiji software (National Institutes of Health, Bethesda, Md.).
Immune Cell Trafficking
Immune cell trafficking was assessed using fluorescein isothiocyanate painting. 21 Briefly, 40 µl of 8% 5 mg/ml fluorescein isothiocyanate (SigmaAldrich) in a 1:1 mixture of acetone and dibutyl phthalate (Sigma-Aldrich) was painted onto hind paws. Eighteen hours later, ipsilateral inguinal lymph nodes were harvested for flow cytometry as described below.
Immunohistochemistry
Immunofluorescent staining was performed according to prior protocols. 18 Tissues were fixed in 4% paraformaldehyde (Affymetrix, Cleveland, Ohio) before paraffin-embedding. Hindlimb tissues also underwent 2 weeks of decalcification with 0.5 M ethylenediaminetetraacetic acid (Santa Cruz Biotechnology, Inc., Dallas, Texas). Blocks were cut into 5-µm sections, which were rehydrated before heat-mediated antigen retrieval using sodium citrate (Sigma-Aldrich) in a 90 o C water bath. Sections were incubated overnight at 4 o C with primary antibodies (Table 1) after nonspecific binding was blocked with 20% donkey serum (Sigma-Aldrich) in phosphate-buffered saline for 1 hour at room temperature. After washing, sections were incubated with fluorescent-labeled secondary conjugates (Life Technologies) for 5 hours and then mounted with Mowiol (Sigma-Aldrich).
Mirax imaging software (Zeiss) with Imaris (Bitplane, Zurich, Switzerland) processing or a Leica SP5-U confocal microscope (Leica Microsystems, Inc., Buffalo Grove, Ill.) with Zeiss Zen 2010 software was used for scanning. Cell counts were performed on high-power sections by two blinded reviewers on a minimum of four mice per group and four high-power sections per mouse using a Pannoramic Viewer (3D Histech, Budapest, Hungary). Perilymphatic inflammation was assessed by quantifying cells within 50 µm of lymphatic vessels; the vessel with the greatest amount of inflammation was recorded for each high-power field.
Flow Cytometry
Flow cytometry was performed using previously described methods to assess dendritic cell migration. 13 Single-cell suspensions were obtained through mechanical dissociation and enzymatic digestion with an 8:2:1 mixture of Dispase II, collagenase D, and DNase I (Roche Diagnostics, Indianapolis, Ind.). Cells were stained with antiCD11c (BioLegend, San Diego, Calif.) to identify dendritic cells and 4′,6-diamidino-2-phenylindole (Molecular Probes) to exclude dead cells. A Fortessa flow cytometry analyzer (BD Biosciences, San Jose, Calif.) with BD FACSDiva software was used for data collection, and data were analyzed with FlowJo software (Tree Star, Ashland, Ore.).
Statistical Analysis
Statistical analysis was performed using GraphPad Prism software (GraphPad Software, Inc., San 
RESULTS
Prox1-Haploinsufficient Mice Have Baseline Lymphatic Dysfunction
Studies have shown that Prox1 +/-mice do not display the lymphedema phenotype despite having dilated, mispatterned lymphatic vessels. 11, 12, 22 Consistent with this, Evans blue injection into the ears of Prox1 +/-mice revealed aberrant lymphatic architecture with increased leakiness, as compared with wild-type mice ( Fig. 1, above) . This was corroborated with immunofluorescent imaging with tomato lectin demonstrating dilated vessels with minimal lectin uptake, resulting in a stippled appearance of dye between vessels rather than intraluminal concentration as noted in controls ( Fig. 1, center) .
The anomalous lymphatic morphology in Prox1 +/-mice correlated with modestly but significantly diminished lymphatic transport capacity. Tail lymphoscintigraphy showed that Prox1 +/-mice had a significant decrease in draining lymph node uptake compared with that in wild-type mice by 45 minutes after injection (Fig. 1, below) 
Baseline Lymphatic Dysfunction Results in Increased Inflammation following Lymphatic Injury
We then sought to evaluate how mice with baseline lymphatic dysfunction respond to lymphatic injury by performing popliteal lymph node dissection in both Prox1 +/-and wild-type mice (Fig. 2,  above) . Four weeks postoperatively, we assessed inflammation, diminished lymphatic vessel pumping, and dysfunctional lymphatic transport capacity, all of which are hallmarks of lymphedema.
At baseline, Prox1 +/-mice had more perilymphatic accumulation of CD45 + leukocytes, as compared with wild-type mice, although this difference did not reach statistical significance (Fig. 2, center +/-mice both before and after popliteal lymph node dissection, as compared with wildtype mice. Collectively, such data suggest that baseline lymphatic dysfunction is associated with mild subcutaneous inflammation, which is significantly amplified by lymphatic injury.
Baseline Lymphatic Dysfunction Increases Lymphatic Leakiness and Decreases Pumping after Popliteal Lymph Node Dissection
Knowing that perilymphatic inflammation impairs collecting vessel pumping capacity by disrupting nitric oxide gradients 23, 24 and that 81e pumping regulates as much as two-thirds of total lymphatic transport capacity, 24 we then evaluated whether increased inflammation in Prox1 +/-mice correlated with changes in lymphatic pumping.
Using lymphangiography, we found that Prox1 +/-mice had leakier lymphatic vessels manifesting as accumulation of dye in the skin (dermal backflow) compared with wild-type controls at baseline + lymphatic vessels, with brackets indicating lymphatic vessel diameter. Scale bar = 100 μm. (Below) Quantification of decay-adjusted uptake (below, left; two-way analysis of variance, mean ± SEM; n = 8 per group; p < 0.05), and peak nodal uptake (below, right; unpaired t test, mean ± SD; n = 8 per group; p = 0.0066) of technetium-99m ( 99m Tc) by sacral lymph nodes after technetium-99m injection into the distal tail.
Plastic and Reconstructive Surgery • January 2019 (Fig. 3, above, left) . As in our ear studies (Fig. 1,  above and center) , we also noted abnormal hypertrophic lymphatic vessels in the hindlimbs of prepopliteal lymph node dissection Prox1 +/-mice. These changes were markedly amplified after popliteal lymph node dissection (Fig. 3, above,  right) . Although wild-type mice had a few areas of lymphatic leakiness, particularly around the surgical site, Prox1 +/-mice had many more areas of leakiness, increased dermal backflow, and virtually no dye uptake. Pre-popliteal lymph node dissection Prox1 +/-mice also had a 54 percent decrease in packet frequency compared with wild-type mice, although this difference was not statistically + macrophages (below, right, one-way analysis of variance, mean ± SD; n = 5 per group; four high-power fields per mouse, p = 0.019 and p = 0.026 for before and after popliteal lymph node dissection, respectively) within 50 μm of LYVE-1 + lymphatic vessels. WT, wild-type. Plastic and Reconstructive Surgery • January 2019 significant (Fig. 3, center and below) (p = 0.090). Interestingly, however, the pumping in Prox1 +/-mice was less regular than that in wild-type mice. After popliteal lymph node dissection, this disparity was markedly amplified, such that the popliteal lymph node dissection-treated Prox1 +/-mice had a significant decrease in pumping (Fig. 3, center) (p = 0.039). Although wild-type mice also had notably diminished packet frequency and changes in pumping regularity, there were hardly any contractions in post-popliteal lymph node dissection Prox1 +/-mice, and those that did occur were very irregular.
Changes in lymphatic pumping closely paralleled perilymphatic inducible nitric oxide synthase expression before and after surgery. At baseline, Prox1 +/-mice had more perilymphatic inducible nitric oxide synthase-positive cells as compared with wild-type mice but this was not statistically significant (Fig. 3, below, . Considered together, our findings suggest that baseline lymphatic defects increase capillary and collecting vessel leakiness and decrease collecting vessel pumping. This effect is highly amplified by lymphatic injury, resulting in worse impairment in interstitial fluid uptake by lymphatic vessels and more extensive dermal backflow. The impaired pumping may be, in part, attributable to perilymphatic accumulation of inflammatory cells expressing inducible nitric oxide synthase, which is known to disrupt endogenous endothelial nitric oxide synthase-derived gradients of nitric oxide that regulate lymphatic pumping regularity and force.
Baseline Lymphatic Dysfunction Exacerbates the Effect of Lymphatic Injury on Immune Cell Trafficking
In addition to being responsible for fluid homeostasis and macromolecule absorption, lymphatic vessels also play an essential role in immune cell trafficking. 25 Knowing this, we hypothesized that Prox1 haploinsufficiency not only results in diminished lymphatic transport capacity in general, but also in impaired immune cell migration specifically. To evaluate this, we used fluorescein isothiocyanate painting to assess dendritic cell migration from distal ipsilateral hindlimb tissues to inguinal lymph nodes, which are immediately upstream from the popliteal nodes, 16 before and after popliteal lymph node dissection (Fig. 4, above) . In support of our hypothesis, at baseline, Prox1 +/-mice had 82.6 percent fewer dendritic cells in the lymph nodes as compared with controls (Fig. 4, below) Because studies have shown that dendritic cell migration to nearby lymph nodes increases following injury, 26 we suspected that popliteal lymph node dissection would lead to a greater accumulation of dendritic cells in lymph nodes, especially because inguinal lymph nodes become the closest skin-draining nodes after popliteal lymphadenectomy. Consistent with this, there were significantly more dendritic cells in the nodes of popliteal lymph node dissection-treated wild-type mice compared to their presurgery counterparts (Fig. 4, below Such results provide further evidence that baseline lymphatic defects amplify lymphatic abnormalities postoperatively. Because lymphocytes also exit tissues by means of lymphatic vessels, 27 this also suggests that increased leukocyte accumulation at baseline and following lymphatic injury results, at least in part, from impaired clearance of immune cell infiltration.
85e DISCUSSION
Despite evidence that lymphedema is increasing in prevalence, 28 management of this morbid disease is hindered by lack of knowledge regarding the factors influencing its variable natural history. 29, 30 Some risk factors have been identified, 2, 30, 31 but it remains difficult to predict whether an individual will develop lymphedema and, if he or she does, whether he or she will have mild or severe manifestations. Guidelines based on risk factors have been useful to identify high-risk patients 28, 32 but, ultimately, the development of effective prophylactic regimens requires the understanding of the mechanisms underlying lymphedema pathogenesis in the setting of such risk factors. Recent studies suggest that patients with breast cancer-related lymphedema may have had underlying lymphatic abnormalities that elevated their risk of developing the disease. Cintolesi et al., for example, found that those who were ultimately diagnosed with breast cancer-related lymphedema had constitutively higher lymphatic pump pressures and transport function before cancer treatment. 33 These authors suggested that these patients exhibited increased lymphatic work in response to chronically high preload and that they developed breast cancer-related lymphedema because of lower reserve pump capacity, resulting in gradual lymphatic failure, analogous to that which occurs in hypertensive cardiac failure.
Baseline lymphatic dysfunction may be attributable to a variety of causes. Some have hereditary predisposition secondary to mutations in lymphatic-related genes. 4, 5, 34 Obesity, however, is a common cause; it has been found to be an independent risk factor for lymphedema, possibly because of its negative effect on lymphatic function. 35 Greene et al., for example, found that patients with extreme obesity (body mass index >59 kg/m 2 ) spontaneously developed 
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Plastic and Reconstructive Surgery • January 2019 lymphedema. 36 Using a mouse model of obesity, Weitman et al. showed that diabetes-induced obesity contributed to impaired lymphatic transport function with corresponding changes in lymph node architecture. 8 Further research revealed that such dysfunction corresponds to perilymphatic accumulation of inflammatory cells and lipids, in addition to decreased lymphatic endothelial cell expression of some of the same genes mutated in patients with genetic susceptibility to lymphedema. 5, 6 Finally, by combining obesity and lymphedema models, Savetsky et al. demonstrated that mice with diabetes-induced obesity have increased adipose deposition, inflammation, and reaction to noxious stimuli, compared with lean mice, both at baseline and after lymphatic injury. 7 In this study, we hypothesized that mice with underlying lymphatic abnormalities because of Prox1 haploinsufficiency would have an accentuated response to lymphatic injury similar to that seen in mice with diabetes-induced obesity. Prox1 +/-mice were used because, similar to patients with subclinical lymphatic dysfunction, these mice do not display the lymphedema phenotype, despite evidence of defective lymphatic vessels. 9, 11, 22 Although these mice do develop adult-onset obesity, 22 we used weight-matched controls, thus limiting the potential negative effects of weight gain.
Consistent with our hypothesis, we found that, compared with wild-type mice, Prox1 +/-mice had greater perilymphatic inflammation, decreased lymphatic pumping, and diminished dendritic cell migration after lymphatic injury. Interestingly, pre-popliteal lymph node dissection Prox1 +/-mice shared many of the characteristics observed in popliteal lymph node dissection-treated wild-type mice, even though they do not appear to have lymphedema. The mechanisms underlying these findings need to be further explored, but such results provide additional evidence that baseline lymphatic dysfunction may be important in the development of lymphedema. This is clinically significant, as it suggests that evaluation of baseline lymphatic function in select patients may allow for more accurate patient risk stratification. There is ongoing research seeking to identify the ideal test for lymphatic function in patients, but lymphoscintigraphy and indocyanine green lymphangiography, similar to that performed in mice in this study, have been shown to be effective means of objective and noninvasive detection of early lymphatic disease. 37 Magnetic resonance lymphangiography is also a promising diagnostic option, but is not yet widely available. 38, 39 Ultimately, patients who are found to have preoperative lymphatic dysfunction may then undergo therapeutic measures to increase lymphatic functional reserve before surgery and/or be considered for prophylactic options to prevent secondary lymphedema entirely. 
